Bosh sahifaTWST • NASDAQ
add
Twist Bioscience Corp
32,01 $
Seans yopilganidan keyin:(0,34%)-0,11
31,90 $
Yopilgan:28-noy, 16:40:37 (GMT-5) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
31,70 $
Kunlik diapazon
31,22 $ - 32,10 $
Yillik diapazon
23,30 $ - 55,33 $
Bozor kapitalizatsiyasi
1,96 mlrd USD
Oʻrtacha hajm
1,85 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 99,01 mln | 16,88% |
Joriy xarajat | 80,77 mln | 8,74% |
Sof foyda | -27,14 mln | 21,69% |
Sof foyda marjasi | -27,41 | 33,00% |
Har bir ulushga tushum | -0,45 | 23,73% |
EBITDA | -26,83 mln | 16,12% |
Amaldagi soliq stavkasi | -0,96% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 232,43 mln | -15,91% |
Jami aktivlari | 641,86 mln | 4,48% |
Jami passivlari | 168,90 mln | 19,25% |
Umumiy kapital | 472,96 mln | — |
Tarqatilgan aksiyalar | 61,15 mln | — |
Narxi/balansdagi bahosi | 4,06 | — |
Aktivlardan daromad | -11,64% | — |
Kapitaldan daromad | -13,19% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -27,14 mln | 21,69% |
Operatsiyalardan naqd pul | -11,81 mln | 22,89% |
Sarmoyadan naqd pul | -12,40 mln | -865,21% |
Moliyadan naqd pul | 5,57 mln | 53,68% |
Naqd pulning sof oʻzgarishi | -18,48 mln | -43,20% |
Boʻsh pul | -14,59 mln | -124,74% |
Haqida
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Tashkil etilgan
2013
Xodimlar soni
979
